Correlation Between Yili Chuanning and Hubei Jumpcan

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Yili Chuanning and Hubei Jumpcan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Yili Chuanning and Hubei Jumpcan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Yili Chuanning Biotechnology and Hubei Jumpcan Pharmaceutical, you can compare the effects of market volatilities on Yili Chuanning and Hubei Jumpcan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Yili Chuanning with a short position of Hubei Jumpcan. Check out your portfolio center. Please also check ongoing floating volatility patterns of Yili Chuanning and Hubei Jumpcan.

Diversification Opportunities for Yili Chuanning and Hubei Jumpcan

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Yili and Hubei is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Yili Chuanning Biotechnology and Hubei Jumpcan Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hubei Jumpcan Pharma and Yili Chuanning is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Yili Chuanning Biotechnology are associated (or correlated) with Hubei Jumpcan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hubei Jumpcan Pharma has no effect on the direction of Yili Chuanning i.e., Yili Chuanning and Hubei Jumpcan go up and down completely randomly.

Pair Corralation between Yili Chuanning and Hubei Jumpcan

Assuming the 90 days trading horizon Yili Chuanning Biotechnology is expected to under-perform the Hubei Jumpcan. In addition to that, Yili Chuanning is 1.07 times more volatile than Hubei Jumpcan Pharmaceutical. It trades about -0.22 of its total potential returns per unit of risk. Hubei Jumpcan Pharmaceutical is currently generating about -0.06 per unit of volatility. If you would invest  3,074  in Hubei Jumpcan Pharmaceutical on September 5, 2024 and sell it today you would lose (105.00) from holding Hubei Jumpcan Pharmaceutical or give up 3.42% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Yili Chuanning Biotechnology  vs.  Hubei Jumpcan Pharmaceutical

 Performance 
       Timeline  
Yili Chuanning Biote 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Yili Chuanning Biotechnology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Yili Chuanning sustained solid returns over the last few months and may actually be approaching a breakup point.
Hubei Jumpcan Pharma 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Hubei Jumpcan Pharmaceutical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Hubei Jumpcan may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Yili Chuanning and Hubei Jumpcan Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Yili Chuanning and Hubei Jumpcan

The main advantage of trading using opposite Yili Chuanning and Hubei Jumpcan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Yili Chuanning position performs unexpectedly, Hubei Jumpcan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hubei Jumpcan will offset losses from the drop in Hubei Jumpcan's long position.
The idea behind Yili Chuanning Biotechnology and Hubei Jumpcan Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios